Literature DB >> 20235745

Metabolic abnormalities and coronary heart disease risk in human immunodeficiency virus-infected adults.

Clive R Pullinger1, Bradley E Aouizerat, Caryl Gay, Traci Coggins, Irina Movsesyan, Harvey Davis, John P Kane, Carmen Portillo, Kathryn A Lee.   

Abstract

BACKGROUND: Metabolic syndrome is a combination of risk factors for cardiovascular disease and diabetes, It has been reported to be increased in human immunodeficiency virus (HIV)-infected individuals.
METHODS: In a cohort of HIV-infected adults we examined parameters that contribute to defining the metabolic syndrome and to estimating the 10-year risk of coronary heart disease (CHD). The study group consisted of 296 participants (217 men and 79 women) of mixed ethnicity with a mean age of 45.3 years.
RESULTS: There was an appreciable prevalence of metabolic syndrome (30.0%), with the frequency increasing to 42.5% in those over 50 years of age. Those with the metabolic syndrome had a lower viral load. More women had abdominal obesity (59.5%) than men (20.7%, P < 0.001). The frequency of elevated plasma glucose was higher in females (37.2%) compared to males (16.9%, P = 0.004). High frequencies of decreased high-density lipoprotein cholesterol (HDL-C) and elevated blood pressure were seen in both sexes. Hypertriglyceridemia was less prevalent in African Americans. In those under 50 years of age, the 10-year CHD risk score for men was double that for women (6.2% vs 2.7%, P < 0.001). In older participants, the risk was similar between the sexes, with a third having scores over 10%.
CONCLUSIONS: The prevalence of metabolic syndrome was higher than in most other HIV cohorts. Those with the syndrome had significantly lower viral loads. Mean 10-year Framingham Cardiovascular Risk (FCR) scores were nearly doubled for those with metabolic syndrome. Both researchers and clinicians should consider age as well as sex when assessing patients with HIV infection for risks associated with metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20235745      PMCID: PMC3085320          DOI: 10.1089/met.2009.0094

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  31 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Waist-to-thigh ratio can also be a better indicator associated with type 2 diabetes than traditional anthropometrical measurements in Taiwan population.

Authors:  Yi-Chou Chuang; Kuang-Hung Hsu; Chorng-Jer Hwang; Pai-Min Hu; Tzu-Miao Lin; Wen-Ko Chiou
Journal:  Ann Epidemiol       Date:  2005-09-15       Impact factor: 3.797

3.  Metabolic syndrome: a real threat for HIV-positive patients?: Results from the SIMONE study.

Authors:  Paolo Bonfanti; Elena Ricci; Giuseppe de Socio; Daniela Zeme; Silvia Carradori; Giovanni Penco; Giustino Parruti; Carmela Grosso; Giordano Madeddu; Francesca Vichi; Teresa Bini; Canio Martinelli; Sara Melzi; Tiziana Quirino
Journal:  J Acquir Immune Defic Syndr       Date:  2006-05       Impact factor: 3.731

4.  Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors.

Authors:  Carlos Jericó; Hernando Knobel; Milagro Montero; Jordi Ordoñez-Llanos; Ana Guelar; Juan L Gimeno; Pere Saballs; Jose L López-Colomés; Juan Pedro-Botet
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

Review 5.  Nonalcoholic fatty liver disease.

Authors:  Sandra K Erickson
Journal:  J Lipid Res       Date:  2008-12-12       Impact factor: 5.922

6.  Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.

Authors:  Kristin Mondy; Edgar Turner Overton; Jessica Grubb; Shao Tong; Warren Seyfried; William Powderly; Kevin Yarasheski
Journal:  Clin Infect Dis       Date:  2007-01-22       Impact factor: 9.079

7.  Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006.

Authors:  R Bethene Ervin
Journal:  Natl Health Stat Report       Date:  2009-05-05

8.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

9.  Metabolic syndrome in older HIV-infected patients: data from the CORE50 cohort.

Authors:  Oluwatoyin Adeyemi; Katayoun Rezai; Mieoak Bahk; Sheila Badri; Neena Thomas-Gossain
Journal:  AIDS Patient Care STDS       Date:  2008-12       Impact factor: 5.078

10.  Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy.

Authors:  R Palacios; J Santos; M González; J Ruiz; M Márquez
Journal:  Int J STD AIDS       Date:  2007-03       Impact factor: 1.359

View more
  6 in total

1.  The ongoing need for good physiological investigation: obstructive sleep apnea in HIV patients as a paradigm.

Authors:  Chantal Darquenne; Charles B Hicks; Atul Malhotra
Journal:  J Appl Physiol (1985)       Date:  2014-08-21

2.  Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection.

Authors:  Hua Liang; Zhaojun Duan; Dan Li; Dongliang Li; Zheng Wang; Li Ren; Tao Shen; Yiming Shao
Journal:  Cell Mol Immunol       Date:  2014-08-11       Impact factor: 11.530

Review 3.  Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection.

Authors:  J Gregory Troll
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

4.  Impact of obstructive sleep apnea on cardiometabolic health in a random sample of older adults in rural South Africa: building the case for the treatment of sleep disorders in underresourced settings.

Authors:  Johanna Roche; Dale E Rae; Kirsten N Redman; Kristen L Knutson; Malcolm von Schantz; F Xavier Gómez-Olivé; Karine Scheuermaier
Journal:  J Clin Sleep Med       Date:  2021-07-01       Impact factor: 4.324

5.  Cardiovascular risk assessment: a comparison of the Framingham, PROCAM, and DAD equations in HIV-infected persons.

Authors:  Max Weyler Nery; Celina Maria Turchi Martelli; Erika Aparecida Silveira; Clarissa Alencar de Sousa; Marianne de Oliveira Falco; Aline de Cássia Oliveira de Castro; Jorge Tannus Esper; Luis Carlos Silva e Souza; Marília Dalva Turchi
Journal:  ScientificWorldJournal       Date:  2013-10-21

6.  A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected Population.

Authors:  Kim A Nguyen; Nasheeta Peer; Edward J Mills; Andre P Kengne
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.